2022-05-08-世界卫生组织-INN_Proposed_List_127_-COVID-_2页_84kb

Summary of WHO Proposed INN for COVID-19

• The World Health Organization (WHO) proposes the International Nonproprietary Name (INN) "imelasomeranum" for a substance used in COVID-19 vaccines.

• Proposed INN details: mRNA-based vaccine agent for active immunization against SARS-CoV-2, codon-optimized with modifications to target the Omicron variant, and includes chemical characteristics.

• Consultation period: Open for public comments from May 10 to May 24, 2022, due to exceptional pandemic circumstances, with a shortened duration (two weeks instead of four months).

• This proposal is part of WHO's special INN list (List 127) for COVID-19.